| The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs JD Herman, LR Pepper, JF Cortese, G Estiu, K Galinsky, V Zuzarte-Luis, ... Science translational medicine 7 (288), 288ra77-288ra77, 2015 | 100 | 2015 |
| Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins KK Hanson, AS Ressurreição, K Buchholz, M Prudêncio, ... Proceedings of the National Academy of Sciences 110 (30), E2838-E2847, 2013 | 95 | 2013 |
| A genomic and evolutionary approach reveals non-genetic drug resistance in malaria JD Herman, DP Rice, U Ribacke, J Silterra, AA Deik, EL Moss, ... Genome biology 15, 1-14, 2014 | 43 | 2014 |
| Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response JD Herman, C Wang, C Loos, H Yoon, J Rivera, M Eugenia Dieterle, ... Nature communications 12 (1), 6853, 2021 | 29 | 2021 |
| Genome-wide association studies of drug-resistance determinants SK Volkman, J Herman, AK Lukens, DL Hartl Trends in parasitology 33 (3), 214-230, 2017 | 20 | 2017 |
| Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy JD Herman, C Wang, JS Burke, Y Zur, H Compere, J Kang, R Macvicar, ... Cell Reports Medicine 3 (11), 2022 | 14 | 2022 |
| Treatments for COVID-19 HS Andrews, JD Herman, RT Gandhi Annual Review of Medicine 75, 145-157, 2024 | 8 | 2024 |
| Functional antibodies in COVID-19 convalescent plasma JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, ... Medrxiv, 2021 | 7 | 2021 |
| The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α Signaling L Fagbami, AA Deik, K Singh, SA Santos, JD Herman, SE Bopp, ... ACS infectious diseases 5 (4), 515-520, 2019 | 6 | 2019 |
| The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dualstage target of febrifugine and its analogs. Sci Transl Med 7: 288ra77 JD Herman, LR Pepper, JF Cortese, G Estiu, K Galinsky, V Zuzarte-Luis, ... | 5 | 2015 |
| Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19 JD Herman, C Atyeo, Y Zur, CE Cook, NJ Patel, KM Vanni, EN Kowalski, ... medRxiv, 2022 | 4 | 2022 |
| Accumulation of neutrophil phagocytic antibody features tracks with naturally acquired immunity against malaria in children N Nziza, TM Tran, EA DeRiso, S Dolatshahi, JD Herman, L de Lacerda, ... The Journal of Infectious Diseases 228 (6), 759-768, 2023 | 3 | 2023 |
| A role for Nucleocapsid-specific antibody function in COVID-19 Convalescent plasma therapy JD Herman, C Wang, JS Burke, Y Zur, H Compere, J Kang, R Macvicar, ... medRxiv, 2022.02. 19.22271230, 2022 | 3 | 2022 |
| Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases JD Herman, C Atyeo, Y Zur, CE Cook, NJ Patel, KM Vanni, EN Kowalski, ... Science translational medicine 15 (712), eadf6598, 2023 | 2 | 2023 |
| The time is now: A call for renewed support of infectious diseases physician-scientist trainees in the era of coronavirus disease 2019 J Queen, S Karaba, J Albin, A Karaba, J Howard-Anderson, N Skinner, ... The Journal of Infectious Diseases 224 (9), 1452-1454, 2021 | 2 | 2021 |
| Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and-positive Tanzanian adults S Jongo, LWP Church, F Milando, M Qassim, T Schindler, M Rashid, ... The Journal of Clinical Investigation 134 (6), 2024 | 1 | 2024 |
| Halofuginone: A story of how target identification of an ancient Chinese medicine and multi-step evolution informs malaria drug discovery JD Herman Harvard University, 2014 | 1 | 2014 |
| 404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients J Herman, C Atyeo, Y Zur, C Cook, N Patel, K Vanni, E Kowalski, G Qian, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 474, 2023 | | 2023 |
| Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19 (preprint) J Herman, C Atyeo, Y Zur, C Cook, N Patel, K Vanni, E Kowalski, G Qian, ... | | 2022 |
| A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy (preprint) JD Herman, C Wang, JS Burke, Y Zur, H Compere, J Kang, R Macvicar, ... | | 2022 |
